Serum soluble suppression of tumorigenicity 2 as a novel inflammatory marker predicts the severity of acute pancreatitis

doi:10.3748/wjg.v27.i38.6489

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 38

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3937)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-5) series.

Item

Count

PDF

210

WORD

HTML

2007

Figures (1-4)

133

Tables (1-5)

146

Sum=2590

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

401

Download

946

Sum=1347

Oct 14, 2021 (publication date) through May 30, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Oct 14, 2021; 27(38): 6489-6500
Published online Oct 14, 2021. doi: 10.3748/wjg.v27.i38.6489

Table 2 Levels of Serum soluble suppression of tumorigenicity 2 and C-reactive protein in different acute pancreatitis groups

	*MAP (n =* 55)**	*MSAP (n =* 37)**	*SAP (n =* 31)**	χ²	P value
	Median (IQR)	Median (IQR)	Median (IQR)	χ²	P value
sST2 (pg/mL)	540 (385)	1250 (700)^b	1890 (812)^b^,^d	74.899	0.000
CRP 48 h (mg/L)	59.37 (32.92)	76.54 (31.79)^b	120.78 (56.66)^b^,^d	59.403	0.000

^bP < 0.001 vs mild acute pancreatitis group.

^dP < 0.001 vs moderately severe acute pancreatitis group. AP: Acute pancreatitis; MAP: Mild AP; MSAP: Moderately severe AP; SAP: Severe AP; sST2: Soluble suppression of tumorigenicity 2; CRP: C- reactive protein.

Citation: Zhang Y, Cheng B, Wu ZW, Cui ZC, Song YD, Chen SY, Liu YN, Zhu CJ. Serum soluble suppression of tumorigenicity 2 as a novel inflammatory marker predicts the severity of acute pancreatitis. World J Gastroenterol 2021; 27(38): 6489-6500
URL: https://www.wjgnet.com/1007-9327/full/v27/i38/6489.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i38.6489